Schroder Investment Management Group’s Seres Therapeutics MCRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-4,922
| Closed | -$2.35M | – | 1534 |
|
|
2021
Q2 | $2.35M | Buy |
4,922
+172
| +4% | +$82.1K | ﹤0.01% | 983 |
|
|
2021
Q1 | $1.96M | Buy |
4,750
+221
| +5% | +$91K | ﹤0.01% | 1020 |
|
|
2020
Q4 | $2.22M | Sell |
4,529
-1,238
| -21% | -$607K | ﹤0.01% | 977 |
|
|
2020
Q3 | $3.19M | Buy |
5,767
+415
| +8% | +$230K | 0.01% | 810 |
|
|
2020
Q2 | $509K | Buy |
5,352
+919
| +21% | +$87.4K | ﹤0.01% | 1003 |
|
|
2020
Q1 | $294K | Hold |
4,433
| – | – | ﹤0.01% | 1054 |
|
|
2019
Q4 | $306K | Hold |
4,433
| – | – | ﹤0.01% | 1115 |
|
|
2019
Q3 | $348K | Hold |
4,433
| – | – | ﹤0.01% | 1104 |
|
|
2019
Q2 | $285K | Sell |
4,433
-4,940
| -53% | -$318K | ﹤0.01% | 1051 |
|
|
2019
Q1 | $1.29M | Buy |
9,373
+2,129
| +29% | +$293K | ﹤0.01% | 856 |
|
|
2018
Q4 | $655 | Buy |
7,244
+486
| +7% | +$44 | ﹤0.01% | 958 |
|
|
2018
Q3 | $1.03M | Hold |
6,758
| – | – | ﹤0.01% | 937 |
|
|
2018
Q2 | $1.24M | Buy |
6,758
+3,460
| +105% | +$637K | ﹤0.01% | 893 |
|
|
2018
Q1 | $484K | Hold |
3,298
| – | – | ﹤0.01% | 1062 |
|
|
2017
Q4 | $669K | Hold |
3,298
| – | – | ﹤0.01% | 1053 |
|
|
2017
Q3 | $1.09M | Buy |
+3,298
| New | +$1.09M | ﹤0.01% | 965 |
|